Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-005295
Filing Date
2020-04-30
Accepted
2020-04-30 18:52:06
Documents
1
Period of Report
2020-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5457
  Complete submission text file 0001179110-20-005295.txt   6863
Mailing Address C/O VENTIV HEALTH 200 COTTONTAIL LN. VANTAGE COURT N. SOMERSET NJ 08873
Business Address
BROSHY ERAN (Reporting) CIK: 0001256230 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 20837667

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations